Skip to content
★ Sign in to follow
DD

David Davidson

Executive
Total declarations
304
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (216 ops.)
€33.7M

Latest filing published 07 Apr 2021 for bluebird bio, Inc., €1,074.

Filing timeline

BuySale
David Davidson

First 200 filings with a declared amount

Insider track record

Disclosed buys
0
Disclosed sells
216
Signal history

David Davidson: trading record in brief

David Davidson discloses dealings in bluebird bio, Inc. to SEC (Form 4). In total, 304 filings cover trades dated from 16 December 2013 to 5 April 2021.

Sales make up the whole of the open-market record (216 sales, €33.7M). Besides market trades, the filings include 8 share grants and 80 option exercises. 2021 to date brings no purchases and 7 sales.

The newest entry dates from 7 April 2021: an open-market sale of €1,074, in bluebird bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to David Davidson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations303 total
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    1,269 USD29SEC
    42 shares@ US$30.210.0% of flowCommon StockSEC:0001562180-21-002737:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    1,242 USD29SEC
    42 shares@ US$29.580.0% of flowCommon StockSEC:0001562180-21-001971:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    19,656 USD29SEC
    698 shares@ US$28.160.1% of flowCommon StockSEC:0001562180-21-001272:2
  • ◆
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    0SEC
    10,000 shares0Common StockSEC:0001562180-21-001272:0
  • ◆
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    0SEC
    2,271 shares0Common StockSEC:0001562180-21-001272:1
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    2,894 USD29SEC
    63 shares@ US$45.930.0% of flowCommon StockSEC:0001562180-21-000911:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    2,158 USD29SEC
    48 shares@ US$44.950.0% of flowCommon StockSEC:0001562180-21-000266:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    82,493 USD29SEC
    1,843 shares@ US$44.760.2% of flowCommon StockSEC:0001562180-21-000266:1
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    60,189 USD29SEC
    1,324 shares@ US$45.460.2% of flowCommon StockSEC:0001562180-21-000266:2
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    2,864 USD29SEC
    62 shares@ US$46.18950.7% of flowCommon StockSEC:0001562180-20-007078:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    93 USD29SEC
    2 shares@ US$46.500.0% of flowCommon StockSEC:0001562180-20-007078:1
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    2,363 USD29SEC
    45 shares@ US$52.50870.6% of flowCommon StockSEC:0001562180-20-006544:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    646 USD29SEC
    12 shares@ US$53.82720.2% of flowCommon StockSEC:0001562180-20-006544:1
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    327 USD29SEC
    6 shares@ US$54.4340.1% of flowCommon StockSEC:0001562180-20-006544:2
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    3,377 USD29SEC
    64 shares@ US$52.7650.9% of flowCommon StockSEC:0001562180-20-006306:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    2,403 USD29SEC
    41 shares@ US$58.600.6% of flowCommon StockSEC:0001562180-20-005919:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    1,870 USD29SEC
    31 shares@ US$60.320.5% of flowCommon StockSEC:0001562180-20-005316:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    682 USD29SEC
    11 shares@ US$61.980.2% of flowCommon StockSEC:0001562180-20-005316:1
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    2,586 USD29SEC
    42 shares@ US$61.570.7% of flowCommon StockSEC:0001562180-20-005060:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    634 USD29SEC
    10 shares@ US$63.360.2% of flowCommon StockSEC:0001562180-20-004289:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    2,056 USD29SEC
    32 shares@ US$64.240.6% of flowCommon StockSEC:0001562180-20-004289:1
  • ◆
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    0SEC
    1,615 shares0Common StockSEC:0001562180-20-003354:0
  • ◆
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    0SEC
    10,000 shares0Common StockSEC:0001562180-20-002152:0
  • ▼
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    296,631 USD29SEC
    3,297 shares@ US$89.971.9% of flowCommon StockSEC:0001562180-20-000308:0
  • ◇
    Chief Medical OfficerExecutivesbluebird bio, Inc.
    151,530 USD11SEC
    3,000 shares@ US$50.510.7% of flowCommon StockSEC:0001209191-19-049169:0

25 of 303 declarations